Fitch, R., Mould, D. R., Conoscenti, V., Huang, R., & Harper, D. Phase 1 Study Evaluating the Pharmacokinetics, Dose Proportionality, Bioavailability, and Tolerability of Subcutaneous Levothyroxine Sodium (XP‐8121). Wiley.
Chicago Style (17th ed.) CitationFitch, Richard, Diane R. Mould, Valentina Conoscenti, Robbie Huang, and Dawn Harper. Phase 1 Study Evaluating the Pharmacokinetics, Dose Proportionality, Bioavailability, and Tolerability of Subcutaneous Levothyroxine Sodium (XP‐8121). Wiley.
MLA (9th ed.) CitationFitch, Richard, et al. Phase 1 Study Evaluating the Pharmacokinetics, Dose Proportionality, Bioavailability, and Tolerability of Subcutaneous Levothyroxine Sodium (XP‐8121). Wiley.
Warning: These citations may not always be 100% accurate.